மருத்துவ சோதனைகள் ஆராய்ச்சி அலகு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ சோதனைகள் ஆராய்ச்சி அலகு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ சோதனைகள் ஆராய்ச்சி அலகு Today - Breaking & Trending Today

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen Läi , United Kingdom , West Midlands , United Kingdom General , Richard Procter , Kay Adeboye , Mike Bradburn , Samuel Hinks , Mona Bafadhel , James Chalmers , Samuel Mills , Dominick Shaw , Claire Millins , Chris Rogers , Peter Howarth , Najib Rahman , Paul Little , Peter Mcquitty , Elizabeth Hamilton , David Connell , Patrick Julier , Thomas Knight , Anne Francis , Rebecca Brown , Lucy Eldridge , Lou Chan ,

ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology
ASLAN PHARMACEUTICALS LIMITEDMay 5, 2021 GMT
- ASLAN will give a poster presentation of new data from its Single Ascending Dose (SAD) study of ASLAN004, during the virtual event on 6 May, 2021
SINGAPORE, May 05, 2021 (GLOBE NEWSWIRE) ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that an abstract on ASLAN004 has been accepted for poster presentation at the upcoming 2021 Society for Investigative Dermatology (SID) virtual meeting between 3-8 May, 2021. The data is available to view during the Pharmacology and Drug Development segment on 6 May, 2.30pm to 4pm EST, and will be published in the fall edition of the Journal of Investigative Dermatolog ....

Singapore General , Hartina Hajireen , Robert Uhl , Emma Thompson , Commission File No , Exchange Commission On , Company Us Securities , Society For Investigative Dermatology , Pharmaceuticals Nasdaq , Drug Development , Exchange Commission , Company Annual Report On Form , Spurwing Communications , Clinical Trials Research Unit , Single Ascending Dose , Investigative Dermatology , Clinical Trials , Research Unit , Changi General Hospital , Multiple Ascending Dose , Commission File , Annual Report , சிங்கப்பூர் ஜநரல் , ராபர்ட் அல் , எம்மா தாம்சன் , தரகு கோப்பு இல்லை ,